PANACHE NSE filing

Panache Digilife Allots 29.28 Lakh Warrants on Preferential Basis, Raising ₹19.32 Crore

The RealCase readMedium impact Positive

Panache Digilife allotted 29.28 lakh warrants on a preferential basis, raising ₹19.32 crore. These warrants are convertible into equity shares within 18 months.

Why it matters

The capital infusion of ₹19.32 crore (and potential future ₹57.69 crore upon conversion) is significant for the company. However, the eventual conversion of warrants into equity shares will lead to dilution for existing shareholders, hence a medium impact.

The market read

The allotment of warrants indicates successful capital raising for the company, reflecting investor confidence from both promoter and non-promoter categories. This fresh capital infusion can support future growth initiatives.

* Panache Digilife Limited has allotted 29,28,652 (Twenty-Nine Lakhs Twenty-Eight Thousand Six Hundred Fifty-Two) warrants convertible into equity shares on a preferential basis. * The Board of Directors approved this allotment through a Circular Resolution effective Monday, 17th November 2025. * This follows the approval of shareholders at their Extra-Ordinary General Meeting held on 18th October 2025, and in-principle approval from NSE Limited on 3rd November 2025 for issuing up to 37,56,000 warrants. * The company has received an aggregate amount of ₹19,32,91,032 (Rupees Nineteen Crore Thirty-Two Lakhs Ninety-One Thousand Thirty-Two) at a rate of ₹66 per warrant, representing 25% of the issue price. * Each warrant has an issue price of ₹263, which includes a warrant subscription price of ₹66 and a warrant exercise price of ₹197. The total aggregated value of the allotment is ₹77,02,35,476 (Rupees Seventy-Seven Crore Two Lakh Thirty-Five Thousand Four Hundred Seventy-Six). * The warrants were allotted to members of the promoter group and non-promoter public. * Each warrant is convertible into one fully paid-up equity share of ₹10 face value upon payment of the balance consideration of ₹197 per warrant. * The conversion option against each warrant can be exercised within a maximum period of 18 months from the date of allotment.

Filing to action

What to do with a filing like this

Panache Digilife Limited filed this with the NSE as a statutory disclosure, categorised under preferential allotment. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Panache Digilife Limited. Read the original for the full detail.

View original filing